Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Science

• Publication date

  2006-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1132341PMID 16990514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuregulin-1 and Myelination

  2006cited by this paper
• BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions

  2005cited by this paper
• Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice*

  2005cited by this paper
• Neuregulin-1 type III determines the ensheathment fate of axons.

  2005cited by this paper
• Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2.

  2005cited by this paper
• β Subunits of Voltage-gated Sodium Channels Are Novel Substrates of β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE1) and γ-Secretase*

  2005cited by this paper
• Axonal Neuregulin-1 Regulates Myelin Sheath Thickness

  2004cited by this paper
• Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1.

  2004cited by this paper
• Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation

  2004cited by this paper
• Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation.

  2004cited by this paper
• Beta-secretase inhibition for the treatment of Alzheimer's disease--promise and challenge.

  2004cited by this paper
• Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

  2004cited by this paper
• Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1).

  2004cited by this paper
• Cleavage of Amyloid-β Precursor Protein and Amyloid-β Precursor-like Protein by BACE 1*

  2004cited by this paper
• Current progress in beta-amyloid immunotherapy.

  2004cited by this paper
• BACE1: the beta-secretase enzyme in Alzheimer's disease.

  2004cited by this paper
• Characterization of α2,6-Sialyltransferase Cleavage by Alzheimer's β-Secretase (BACE1)*

  2003cited by this paper
• Characterization of alpha 2,6-sialyltransferase cleavage by Alzheimer's beta -secretase (BACE1).

  2003cited by this paper
• Identification of a (cid:1) -Secretase Activity, Which Truncates Amyloid (cid:1) -Peptide after Its Presenilin-dependent Generation*

  2003cited by this paper
• β-Secretase Cleavage at Amino Acid Residue 34 in the Amyloid β Peptide Is Dependent upon γ-Secretase Activity*

  2003cited by this paper
• The Cell Adhesion Protein P-selectin Glycoprotein Ligand-1 Is a Substrate for the Aspartyl Protease BACE1*

  2003cited by this paper
• Neuregulins and the neuromuscular system: 10 years of answers and questions

  2003cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Mitogen-activated protein kinase-dependent and -independent routes control shedding of transmembrane growth factors through multiple secretases.

  2002cited by this paper
• The breast proto-oncogene, HRGα regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland

  2002cited by this paper
• BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.

  2001cited by this paper
• Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

  2001cited by this paper
• BACE1 is the major β-secretase for generation of Aβ peptides by neurons

  2001cited by this paper
• Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase.

  2001cited by this paper
• The functional gamma-secretase inhibitor prevents production of amyloid beta 1-34 in human and murine cell lines.

  2001cited by this paper
• The N-terminal Region of Neuregulin Isoforms Determines the Accumulation of Cell Surface and Released Neuregulin Ectodomain*

  2001cited by this paper
• BACE2 Functions as an Alternative α-Secretase in Cells*

  2001cited by this paper
• ErbB‐4 and neuregulin expression in the adult mouse olfactory bulb after peripheral denervation

  2001cited by this paper
• BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.

  2001cited by this paper
• The functional γ-secretase inhibitor prevents production of amyloid β 1–34 in human and murine cell lines

  2001cited by this paper
• Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-alpha-converting enzyme.

  2000cited by this paper
• BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein.

  2000cited by this paper
• Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.

  2000cited by this paper
• BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein

  2000cited by this paper
• Neuregulin, a factor with many functions in the life of a Schwann cell

  2000cited by this paper
• A Dual Role of erbB2 in Myelination and in Expansion of the Schwann Cell Precursor Pool

  2000cited by this paper
• Differential Shedding of Transmembrane Neuregulin Isoforms by the Tumor Necrosis Factor-α-Converting Enzyme

  2000cited by this paper
• ASP1 (BACE2) cleaves the amyloid precursor protein at the beta-secretase site.

  2000cited by this paper
• Identification of a novel aspartic protease (Asp 2) as beta-secretase.

  1999cited by this paper
• Binding specificities and affinities of egf domains for ErbB receptors

  1999cited by this paper
• Cellular mechanisms of beta-amyloid production and secretion.

  1999cited by this paper
• Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity

  1999cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper

• Ramalin Ameliorates Alzheimer's Disease Pathology by Targeting BACE1, HDAC6, and MAPK Pathways

  2026cites this paper
• Identifying Potential BACE1 Inhibitors from the ChEMBL Database Using Machine Learning and Atomistic Simulation Approaches.

  2026cites this paper
• A Novel RAGE Modulator Induces Soluble RAGE to Reduce BACE1 Expression in Alzheimer's Disease

  2025cites this paper
• BACE1: Biological Functions and Involvement in the Pathophysiology of Alzheimer's Disease and Other Neurological Disorders

  2025cites this paper
• Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment

  2025cites this paper
• Tight Spaces, Tighter Signals: Spatial Constraints as Drivers of Peripheral Myelination

  2025cites this paper
• Diversification of dentate gyrus granule cell subtypes is regulated by Nrg1 nuclear back-signaling

  2025cites this paper
• BACE1 regulates sleep–wake cycle through both enzymatic and non–enzymatic actions

  2025cites this paper
• RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer’s disease mouse models

  2025cites this paper
• Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer’s disease

  2024cites this paper
• Eta-secretase-like processing of the amyloid precursor protein (APP) by the rhomboid protease RHBDL4

  2024cites this paper
• BACE1 inhibitor drugs for the treatment of Alzheimer's disease: Lessons learned, challenges to overcome, and future prospects†.

  2024cites this paper
• Early Animal Origin of BACE1 APP/Aβ Proteolytic Function

  2024cites this paper
• Membrane-Targeted Quantum Dot-Based BACE1 Activity Sensors for In Vitro and In Cellulo Assays

  2024cites this paper
• Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease

  2024cites this paper
• Polypharmacological profiling across protein target families and cellular pathways using the multiplexed cell-based assay platform safetyProfiler reveals efficacy, potency and side effects of drugs.

  2024cites this paper
• BACE Inhibitor Clinical Trials for Alzheimer’s Disease

  2024cites this paper
• Effect of Functional Inhibition of BACE1 on Sensitization to γ-Irradiation in Cancer Cells

  2024cites this paper
• Recent advances in Alzheimer’s disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein

  2024cites this paper
• Peripheral myelin: From development to maintenance

  2024cites this paper
• PMP2 regulates myelin thickening and ATP production during remyelination

  2024cites this paper
• Spatial transcriptomics and single-nucleus RNA sequencing reveal a transcriptomic atlas of adult human spinal cord

  2023cites this paper
• Tryptamine Derivatives of Sesquiterpene Lactones as Effective β-Secretase 1 Inhibitors

  2023cites this paper
• The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?

  2023cites this paper
• Eta-secretase-like processing of the amyloid precursor protein (APP) by RHBDL4

  2023cites this paper
• The Neurobiology and Therapeutic Potential of Multi-Targeting β-secretase, Glycogen Synthase Kinase 3β and Acetylcholinesterase in Alzheimer's Disease.

  2023cites this paper
• Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds

  2023cites this paper
• BACE1-dependent metabolism of neuregulin 1: Bridging the gap in explaining the occurrence of schizophrenia-like symptoms in Alzheimer's disease with psychosis?

  2023cites this paper
• Amyloid-β Effects on Peripheral Nerve: A New Model System

  2023cites this paper
• Electrochemiluminescence and electrochemical dual-mode detection of BACE1 activity based on the assembly of peptide and luminol co-functionalized silver nanoparticles induced by cucurbit[8]uril.

  2023cites this paper
• A tailored tetravalent peptide displays dual functions to inhibit amyloid β production and aggregation

  2023cites this paper
• BACE1 in PV interneuron tunes hippocampal CA1 local circuits and resets priming of fear memory extinction

  2023cites this paper
• RO6807936 as a Novel PET Radiotracer for in Vitro and in Vivo Visualization and Quantification of BACE1 in the Rodent and Baboon Brain.

  2023cites this paper
• Postnatal neuronal Bace1 deletion impairs neuroblast and oligodendrocyte maturation.

  2022cites this paper
• Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology

  2022cites this paper
• Partial loss‐of‐function variant in neuregulin 1 identified in family with heritable peripheral neuropathy

  2022cites this paper
• Structural dynamics and catalytic modulations of Aβ regulating enzymes as future outlook for Alzheimer's.

  2022cites this paper
• The BACE1-generated C-terminal fragment of the neural cell adhesion molecule 2 (NCAM2) promotes BACE1 targeting to Rab11-positive endosomes

  2022cites this paper
• Amyloid-ß plaque formation and BACE1 accumulation in the brains of a 5xFAD Alzheimer's disease mouse model is associated with altered distribution and not proteolysis of BACE1 substrates Sez6 and Sez6L.

  2022cites this paper
• The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases.

  2022cites this paper
• Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3

  2022cites this paper
• Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer’s disease

  2022cites this paper
• Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing

  2022cites this paper
• Finding New Ways How to Control BACE1

  2022cites this paper
• A novel spinal neuron connection for heat sensation.

  2022cites this paper
• Genetic and molecular biology of gastric cancer among Iranian patients: an update

  2022cites this paper
• AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model

  2022cites this paper
• Beyond Wrapping: Canonical and Noncanonical Functions of Schwann Cells.

  2022cites this paper
• Therapeutic Potential of Targeting Regulated Intramembrane Proteolysis Mechanisms of Voltage-Gated Ion Channel Subunits and Cell Adhesion Molecules

  2022cites this paper
• Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease.

  2022cites this paper
• Co-Immobilized Capillary Enzyme Reactor Based on Beta-Secretase1 and Acetylcholinesterase: A Model for Dual-Ligand Screening

  2021cites this paper
• Myelin Biology

  2021cites this paper
• Activation of Transient Receptor Potential Vanilloid-3 Channels in Keratinocytes Induces Pruritus in Humans

  2021cites this paper
• Title Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system

  2021cites this paper
• Local predictors of anti-Aβ therapy efficacy revealed by quantitative whole-brain microscopy

  2021cites this paper
• New insights in drug development for Alzheimer's disease based on microglia function.

  2021cites this paper
• Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360.

  2021cites this paper
• Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development

  2021cites this paper
• Evaluation of putative CSF biomarkers in paediatric spinal muscular atrophy (SMA) patients before and during treatment with nusinersen

  2021cites this paper
• Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo

  2021cites this paper
• A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria.

  2021cites this paper
• Peripheral Nerve Development and the Pathogenesis of Peripheral Neuropathy: the Sorting Point

  2021cites this paper
• The influence of BACE1 on macrophage recruitment and activity in the injured peripheral nerve

  2021influential citation
• Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

  2021cites this paper
• Structural Study of Membrane Glycoprotein-Precursor of β-Amyloid and Proteins Involved in Its Proteolysis

  2021cites this paper
• The β-Secretase Substrate Seizure 6–Like Protein (SEZ6L) Controls Motor Functions in Mice

  2021cites this paper
• The case for low-level BACE1 inhibition for the prevention of Alzheimer disease

  2021cites this paper
• The pseudoprotease iRhom1 controls ectodomain shedding of membrane proteins in the nervous system

  2021cites this paper
• Preparation and Implementation of a High Throughput Virtual Screening Protocol on a Shared Memory GPU Supercomputer

  2021cites this paper
• Transcriptional activation with Cas9 activator nanocomplexes rescues Alzheimer's disease pathology.

  2021cites this paper
• Endoglycan (PODXL2) is proteolytically processed by ADAM10 (a disintegrin and metalloprotease 10) and controls neurite branching in primary neurons

  2021cites this paper
• Post-Translational Modifications of BACE1 in Alzheimer's Disease

  2021cites this paper
• Insights into T‐cell dysfunction in Alzheimer's disease

  2021cites this paper
• Effect of Schwann cell transplantation combined with electroacupuncture on axonal regeneration and remyelination in rats with spinal cord injury

  2021cites this paper
• Identifying the key residues instrumental in imparting stability to amyloid beta protofibrils – a comparative study using MD simulations of 17–42 residues

  2020cites this paper
• Amyloid beta hypothesis in Alzheimer's disease: Major culprits and recent therapeutic strategies.

  2020cites this paper
• The Nerve to Give BACE Inhibitors a Second Chance?

  2020cites this paper
• Gga3 deletion and a GGA3 rare variant associated with late onset Alzheimer’s disease trigger BACE1 accumulation in axonal swellings

  2020cites this paper
• Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study

  2020cites this paper
• The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer’s Disease

  2020cites this paper
• [The future of dementia prevention and treatment strategies].

  2020cites this paper
• Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

  2020cites this paper
• Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs

  2020cites this paper
• Exploring the landscape of ectodomain shedding by quantitative protein terminomics

  2020cites this paper
• SPON1 Can Reduce Amyloid Beta and Reverse Cognitive Impairment and Memory Dysfunction in Alzheimer’s Disease Mouse Model

  2020cites this paper
• Sex differences in circulating neuregulin1-β1 and β-secretase 1 expression in childhood-onset schizophrenia.

  2020cites this paper
• Schwann Cell Plasticity in Peripheral Nerve Regeneration after Injury

  2020cites this paper
• Expression of BACE1 in the Rat Carotid Body

  2020cites this paper
• The Nerve to Give BACE Inhibitors a Second Chance?

  2020cites this paper
• Macrophage-specific deletion of BACE1 does not enhance macrophage recruitment to the injured peripheral nerve.

  2020cites this paper
• Signaling pathways that regulate glial development and early migration—Schwann cells

  2020cites this paper
• Neurodegenerative and Hepatorenal Disorders Induced Via Aluminum Chloride in Murine System: Impact of β-Secretase, MAPK, and KIM

  2020cites this paper
• Dcf1 alleviates C99-mediated deficits in drosophila by reducing the cleavage of C99.

  2020cites this paper
• Schwann cell development: From neural crest to myelin sheath

  2020cites this paper
• AP‐2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons

  2020cites this paper
• Peptidomimetic Modulators of BACE1

  2020cites this paper
• Robust Biomarkers: Methodologically Tracking Causal Processes in Alzheimer’s Measurement

  2020cites this paper
• Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models

  2020cites this paper
• Mechanisms of Schwann cell plasticity involved in peripheral nerve repair after injury

  2020cites this paper
• The b-Secretase BACE1 in Alzheimer’s Disease

  2020cites this paper